Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction

Key Points

• The aim is to compare the effectiveness of low-dose dopamine and low-dose nesiritide in managing acute heart failure amongst patients with renal dysfunction.
• Randomized trial with participants identified under clinicaltrials.gov Identifier: NCT01132846
• Intervention involving low doses of dopamine and nesiritide
• Evaluation of heart function and renal dynamics
• Low-dose nesiritide resulted in greater improvements in heart function compared to low-dose dopamine.
• Lower rates of adverse effects were observed in the nesiritide group.
• Descriptive outcomes suggest potential benefits of nesiritide in this specific patient population.